Marketing Presentation definition

Marketing Presentation means collectively, the presentation of the Company dated July 2, 2019 and the presentation of the Company dated August 7, 2019, used in connection with the marketing of the Offering;
Sample 1Sample 2
Marketing Presentation means the presentation of the Company dated May 8, 2017 used in connection with the marketing of the Offering;
Sample 1

Examples of Marketing Presentation in a sentence

  • Potential Bidders shall be provided with access to the Dataroom, together with the Marketing Presentation, Brochures and such further information and marketing materials (collectively, the “ Marketing Materials”) as the Receiver or Broker may deem appropriate.

  • Marketing: Presentation of products or services in such a way as to make them desirable.MAXIS: System that processes information to determine eligibility for public assistance programs and mails benefits and notices to people who receive public assistance.

  • PX 399 (PHS Central Region, Great Lakes Marketing Presentation); PX 272 (Commonwealth Fund 2007 scores); PX 2299 (CareChex Hospital Quality Ratings).

  • Marketing Presentation from Tracey Smith from Oxygen Marketing Summit Academy LEA Action items: 1.

  • Contractor shall organize and arrange for the demonstration of the Piped Gas Connection during Marketing Presentation as well as for other purposes mentioned.

  • Images of ‘‘Jing-Jing’’ and ‘‘Cha-Cha’’ from a Web site of the Chinese Internet police 2995 2002 Cisco Marketing Presentation 300(IX) EXECUTIVE SUMMARYThe 2008 Annual Report to Congress of the U.S.-China Economic and Security Review Commission sets forth the Commission’s anal- ysis of the U.S.-China relationship in the topical areas designated by the Commission’s Congressional mandate: the areas for the Commission to consider and about which it is to make rec- ommendations to the Congress.

  • Items tentatively scheduled for the next City Council meeting include: Placerville Economic Advisory Committee Report to Council, Marketing Presentation by Jody Franklin, 2021 Housing Element Progress Report, Smith Flat Road Surveying Contract, Hangtown Creek Culvert and Parking Lot Restoration (at Tap House),Dick’s Sporting Goods Check Presentation, and Police AB 481 Report.

  • Items tentatively scheduled for the next City Council meeting include: Adoption of Fire Code, Water/Sewer Rates Study contract, PPOA MOU, Click2Gov Business License Software Demonstration, Chamber Marketing Presentation, County Wildfire Mitigation Presentation - Ken Pimlott, Presentation: California Department of Insurance - Durriya Syed, Cottonwood 4&6 CFD Resolution of Intent, Clay Street Dewberry Amendment, Secondary Clarifier #1 Contracts, Front Yard Fence Height Ordinance, and A-Board Sign Discussion.

  • Community Marketing Presentation: The E.D. met with Community Marketing Associates staff and Ted Coutilish/EMU to discuss partnership opportunities and a proposal for public relations assistance for the Downtown.Dumpster Management: The E.D. met with several of the stakeholders regarding the dumpster located in the south alley of the 200 block of W.

  • UNIT-IIFuture trends of IT: AI, Robots, Neural Networks, Fuzzy logic, Virtual Reality, Developments in hardware and software, economic role of IT (Banking and Finance, Stock market), IT and Manufacturing, IT in Retail Marketing, Presentation on future trends.

Related to Marketing Presentation

  • Marketing Plan means a plan or system concerning a material aspect of conducting business. Indicia of a marketing plan include any of the following:

  • Marketing Materials has the meaning ascribed thereto in NI 41-101;

  • Marketing program means a program established by order of the director pursuant to this act prescribing rules and regulations governing the marketing for processing, distributing, selling, or handling an agricultural commodity produced in this state or agricultural commodity input during a specified period and

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Development Report means a written account of Licensee’s progress under the Development Plan having at least the information specified on Appendix B to this Agreement, and shall be sent to the address specified on Appendix B.

  • Marketing Authorization Application or “MAA” means an application to the appropriate Regulatory Authority for approval to sell the Product (but excluding Pricing Approval) in any particular country or regulatory jurisdiction.

  • Marketing Material means (a) customary bank books, information memoranda and other information packages regarding the business, operations, financial condition, projections and prospects of the Companies and their Subsidiaries, including all information relating to the transactions contemplated hereunder and (b) a customary “road show presentation” and a preliminary and final offering memorandum or private placement memorandum that is suitable for use in a customary “high-yield road show”, in each case required in connection with the Financing.

  • Research Analyst means any individual employed by Loomis Sayles who has been designated as a Research Analyst or Research Associate by Loomis Sayles. A person is considered a Research Analyst only as to those Covered Securities which he or she is assigned to cover and about which he or she issues research reports to other Investment Persons or otherwise makes recommendations to Investment Persons beyond publishing their research. As to other securities, he or she is simply an Access Person.

  • Project Management Report means each report prepared in accordance with Section 4.02 of this Agreement;

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Forensic analysis means the practice of gathering, retaining, and analyzing computer-related data for investigative purposes in a manner that maintains the integrity of the data.

  • Initial Development Plan has the meaning set forth in Section 3.2(b).

  • Supplemental Marketing Material means any Issuer Free Writing Communication other than any Issuer Free Writing Communication specified in Schedule B hereto. Supplemental Marketing Materials include, but are not limited to, any Issuer Free Writing Communication listed on Schedule C hereto.

  • Commencement of Commercial Production means the first occurrence of Commercial Production in an Area.

  • Marketing means a direct or indirect offering or placement at the initiative of the AIFM or on behalf of the AIFM of units or shares of an AIF it manages to or with investors domiciled or with a registered office in the Union;

  • Commercial Product means any such product as defined in FAR 2.101.

  • Licensed behavior analyst means a person who holds current certification or meets the standards to be certified as a board certified Behavior Analyst or a board certified Assistant Behavior Analyst issued by the Behavior Analyst Certification Board, Inc., or any successor in interest to that organization and whom the Board of Psychological Examiners licenses as a Behavior Analyst.

  • Marketing Agreement means an agreement entered into, with the director, by producers, distributors, processors, or handlers pursuant to this act and binding only on those signing the agreement.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Commercial Production means the operation of the Property or any portion thereof as a producing mine and the production of mineral products therefrom (excluding bulk sampling, pilot plant or test operations);

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • Marketing Information means marketing studies, marketing analyses, and similar research and information designed to identify potential customers and business relationships.

  • Commercial Development Plan means the written commercialization plan attached as Appendix E.

  • Drug paraphernalia means all equipment, products, and materials of any kind, which are used for injecting, ingesting, inhaling or otherwise introducing a drug into the human body. This includes, but is not limited to, all equipment, products and materials prohibited or controlled by State or Federal laws.

  • Peer-reviewed medical literature means a published scientific study in a journal or other publication in which original manuscripts have been published only after having been critically reviewed for scientific accuracy, validity and reliability by unbiased independent experts, and that has been determined by the international committee of medical journal editors to have met the uniform requirements for manuscripts submitted to biomedical journals. Peer-reviewed medical literature does not include publications or supplements to publications that are sponsored to a significant extent by a pharmaceutical manufacturing company or health carrier.

  • Remarketing Materials means (i) the Fund’s most recent annual report and, if available, subsequent semi-annual report, which shall be deemed to have been made available upon the electronic availability of any such document on a public website, (ii) the most recent annual and, if available, interim report of the Liquidity Provider, which shall be deemed to have been made available upon the electronic availability of any such document on a public website, (iii) such other publicly available information as the Fund or the Liquidity Provider or the Remarketing Agent, if applicable, may reasonably request from time to time, of the Liquidity Provider, the Fund or the Remarketing Agent, and such other documentation, representations, warranties and certifications as the Fund, the Liquidity Provider or the Remarketing Agent, if applicable, may reasonably request, it being understood that the Fund, the Liquidity Provider or the Remarketing Agent, if applicable, may, in its discretion, determine to deliver to purchasers and prospective purchasers, in connection with the offer and sale of VRDP Shares by the Liquidity Provider, a Remarketing Memorandum, and (iv) such other publicly available information necessary, in the opinion of counsel for the Fund, the Liquidity Provider or the Remarketing Agent, if applicable, to amend or supplement the foregoing materials, in order that the foregoing materials will not include any untrue statements of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time made available to or delivered to a purchaser.